HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases

Conditions:   HER2/Neu Positive;   Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Brain;   Metastatic Malignant Neoplasm in the Leptomeninges Intervention:   Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials